Compare CRBP & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRBP | FCCO |
|---|---|---|
| Founded | 2009 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.6M | 234.2M |
| IPO Year | N/A | 1998 |
| Metric | CRBP | FCCO |
|---|---|---|
| Price | $9.69 | $30.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $50.29 | $30.00 |
| AVG Volume (30 Days) | ★ 513.0K | 29.9K |
| Earning Date | 11-12-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 2.09% |
| EPS Growth | N/A | ★ 42.01 |
| EPS | N/A | ★ 2.40 |
| Revenue | N/A | ★ $74,989,000.00 |
| Revenue This Year | N/A | $23.03 |
| Revenue Next Year | $100.00 | $27.07 |
| P/E Ratio | ★ N/A | $12.77 |
| Revenue Growth | N/A | ★ 19.52 |
| 52 Week Low | $4.64 | $19.46 |
| 52 Week High | $20.56 | $30.78 |
| Indicator | CRBP | FCCO |
|---|---|---|
| Relative Strength Index (RSI) | 34.73 | 74.74 |
| Support Level | $9.44 | $29.03 |
| Resistance Level | $11.64 | $29.57 |
| Average True Range (ATR) | 0.74 | 0.53 |
| MACD | -0.02 | 0.16 |
| Stochastic Oscillator | 12.16 | 93.62 |
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.